Anvari M, Paterson C A, Daniel E E, McDonald T J
Department of Surgery, McMaster University, Hamilton, Ontario, Canada.
Dig Dis Sci. 1998 Jun;43(6):1133-40. doi: 10.1023/a:1018863716749.
Glucagon-like polypeptide 1 (GLP-1) may be a major enterogastrone, slowing gastric emptying when released by intestinal nutrients. In six conscious dogs, we studied the effects of GLP-1, on antropyloric motility, gastric emptying, and transpyloric flow after instillation of 500 ml of saline into the stomach. The meal was given and recordings were started 15 min after intravenous bolus and infusion of either saline or three different doses of GLP-1. Intravenous GLP-1 produced a dose-related retardation of gastric emptying associated with a decrease in the number and volume of flow pulses in comparison to saline. This change in transpyloric flow was associated with an inhibition of antropyloric pressure waves, a stimulation of isolated pyloric pressure waves, and an increase in basal pyloric tone induced by intravenous GLP-1 infusion. Our findings show that GLP-1 has a potent dose-dependent inhibitory effect on transpyloric flow and gastric emptying. This effect is temporally associated with inhibition of antral "pumping" and stimulation of pyloric "braking" mechanisms.
胰高血糖素样肽1(GLP-1)可能是一种主要的肠抑胃素,在肠道营养物质释放时可减缓胃排空。在6只清醒犬中,我们在向胃内注入500 ml生理盐水后,研究了GLP-1对胃幽门运动、胃排空及经幽门流量的影响。给予进食,并在静脉推注及输注生理盐水或三种不同剂量的GLP-1 15分钟后开始记录。与生理盐水相比,静脉注射GLP-1可导致与胃排空延迟相关的剂量依赖性变化,同时流量脉冲的数量和体积减少。经幽门流量的这种变化与胃幽门压力波的抑制、孤立幽门压力波的刺激以及静脉输注GLP-1引起的基础幽门张力增加有关。我们的研究结果表明,GLP-1对经幽门流量和胃排空具有强大的剂量依赖性抑制作用。这种作用在时间上与胃窦“泵吸”的抑制和幽门“制动”机制的刺激相关。